Convidecia (Ad5-nCoV)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Convidecia (Ad5-nCoV), covering 2025-02-21 to 2025-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Heterologous Prime-boost Immunization with an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming with an Inactivated SARS-CoV-2 Vaccine [Phase 1, Phase 2]